市場調查報告書

全球醫療用酵素趨勢·佔有率·成長預測 (2020-2027年):原料 (醣類水解酵素·蛋白分解酵素)·產品·技術·用途·適應症·終端用戶·各地區

Healthcare Specialty Enzymes Market Size, Share & Trends Analysis Report By Source (Carbohydrases, Proteases), By Product, By Technique, By Application, By Usage, By End Use, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 968630
出版日期 內容資訊 英文 210 Pages
商品交期: 2-3個工作天內
價格
全球醫療用酵素趨勢·佔有率·成長預測 (2020-2027年):原料 (醣類水解酵素·蛋白分解酵素)·產品·技術·用途·適應症·終端用戶·各地區 Healthcare Specialty Enzymes Market Size, Share & Trends Analysis Report By Source (Carbohydrases, Proteases), By Product, By Technique, By Application, By Usage, By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年10月19日內容資訊: 英文 210 Pages
簡介

全球醫療用酵素的市場規模在預測期間內預計將以6.2%的年複合成長率推移,到2027年達到38億美元的規模。醫療應用中的酶滲透率以及對酶在診斷和治療中的潛力的廣泛研究等因素正在推動市場的增長。診斷性血清酶吸引了人們的注意,因為它們提供了對異常組織和器官的有用見解,並有助於預測組織易受損害的區域。

本報告提供全球醫療用酵素的市場調查,彙整市場定義和概要,市場成長的各種影響因素分析,市場規模的轉變·預測,產品·原料·技術·用途·適應症·終端用戶·地區等各種區分的明細,競爭環境,主要企業簡介等資料。

第1章 調查手法·調查範圍

第2章 摘要整理

第3章 市場可變因素·趨勢·範圍

  • 市場分類·調查範圍
  • 普及·成長預測製圖
  • SWOT分析
  • 波特的五力分析
  • 酵素製造業:近幾年趨勢

第4章 市場分析·預測:各產品

  • 醣類水解酵素
  • 聚合酵素·核酸水解酵素
  • 蛋白分解酵素
  • 解脂酵素
  • 磷酸酶/植酸酵素
  • 其他的產品

第5章 市場分析·預測:各原料

  • 微生物
  • 動物
  • 植物

第6章 市場分析·預測:各技術

  • 臨床化學
  • 分子診斷
  • 免疫診斷
  • 微生物學
  • 血液學

第7章 市場分析·預測:各用途

  • 研究·生物科技
  • 診斷

第8章 市場分析·預測:各適應症

  • 感染疾病
  • 糖尿病
  • 腫瘤學
  • 心臟病
  • 腎臟學
  • 自體免疫疾病

第9章 市場分析·預測:各終端用戶

  • 醫院
  • 實驗室
  • 其他

第10章 市場分析·預測:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第11章 企業簡介

  • 策略性架構
  • 市場進入經營者的分類
  • 企業簡介
目錄
Product Code: GVR-4-68039-213-5

Healthcare Specialty Enzymes Market Growth & Trends

The global healthcare specialty enzymes market size is estimated to reach USD 3.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2020 to 2027. Increasing penetration of enzymes in medical applications serves to be a key driving factor for the market. This is also supplemented by extensive research studies being carried out to explore the potential of enzymes in diagnosis as well as therapy. Diagnostic serum enzymes have gained significant attention for the quantification of these offers useful insights regarding abnormal tissue or an organ and help in predicting sites that are susceptible to tissue damage.

Certain products such as aldolase, Creatine Phosphokinase (CPK), gamma-glutamyl transpeptidase, lactic dehydrogenase, lipase, and transaminases are routinely adopted for disease diagnosis. Aldolase is preferably used in the early-stage diagnosis of viral hepatitis as well as advanced prostate cancer. Whereas, CPK has caught the attention of healthcare professionals in terms of both diagnosis and research. CPK tests are performed to diagnose cardiac abnormalities, muscle-associated conditions along with differentiation of post-operative infection from malignant hyperthermia. Thus, the use of enzyme products expanding across various diagnostic applications is set to propel the demand for these products in the healthcare industry.

Enzyme dependent analytical procedures are carried out on a large scale; specificity and potency of these procedures enable amplification as well as detection of a specific target analyte. This has propelled the use of enzyme-based assays in the field of wet chemistry for the quantification of target substances and drugs. Soaring demand for immunodiagnostics, especially Enzyme-linked Immunosorbent Assay (ELISA) boosts the use of specialty enzymes in the amplification of the target signal. Whereas regular use of DNA polymerase for DNA amplification in DNA fingerprinting has increased considerably over the years.

Healthcare Specialty Enzymes Market Report Highlights

  • Carbohydrases accounted for the highest revenue share in 2019 and are anticipated to maintain this trend from 2020 to 2027
  • A major contribution to the revenue generated by this segment in the market is done by amylases and cellulases, as amylases are employed in several biotechnology applications
  • The phosphatase/phytase product segment is set to grow at the fastest pace from 2020 to 2027
  • This is attributed to the rise in use of alkaline phosphatases inclusive of zinc and magnesium ions, which is favored in pharmaceutical applications along with clinical analysis
  • The research and biotechnology end-use segment has generated the highest revenue in 2019, accounting for a share of 64.7%
  • Employment of these products in a diverse range of usages pertaining to DNA modification has been observed in the research and biotechnology studies. In addition, this sector is expected to witness rapid growth with respect to the incorporation of these consumables
  • North America accounted for the highest share of 38.2% in 2019 and is expected to maintain this dominance through 2020 to 2027, attributed to the high penetration of novel diagnostic techniques
  • The Asia Pacific is expected to offer lucrative opportunities for market expansion, attributed to the rising focus on the infectious disease diagnosis
  • A robust network of local manufacturers has significantly contributed to the revenue generated by APAC in the market

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Significant developments in the research and biotechnology space
      • 3.1.1.2 Technological advancements in enzyme-based monitoring
      • 3.1.1.3 Rising demand for specialty enzymes in the prognosis of diseases
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Risks associated with an enzyme-based diagnosis
  • 3.2 Penetration & Growth Prospect Mapping for Product, 2019
  • 3.3 Healthcare Specialty Enzymes Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's
  • 3.5 Enzyme Manufacturing Industry: Recent Trends
    • 3.5.1 Enzyme Manufacturing Industry Scenario For Developing Economies
      • 3.5.1.1 Key recommendations for the enzyme manufacturing in developing economies

Chapter 4 Healthcare Specialty Enzymes: Product Business Analysis

  • 4.1 Healthcare Specialty Enzymes Market: Product Movement Analysis
  • 4.2 Carbohydrases
    • 4.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 4.3 Polymerases and Nucleases
    • 4.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 4.4 Protease
    • 4.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 4.5 Lipases
    • 4.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 4.6 Phosphatases/Phytases
    • 4.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 4.7 Other Products
    • 4.7.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 5 Healthcare Specialty Enzymes: Source Business Analysis

  • 5.1 Market: Source Movement Analysis
  • 5.2 Microorganisms
    • 5.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 5.3 Animals
    • 5.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 5.4 Plants
    • 5.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6 Healthcare Specialty Enzymes: Technique Business Analysis

  • 6.1 Market: Technique Movement Analysis
  • 6.2 Clinical Chemistry
    • 6.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.3 Molecular Diagnostics
    • 6.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.4 Immunodiagnostics
    • 6.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.5 Microbiology
    • 6.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.6 Hematology
    • 6.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 7 Healthcare Specialty Enzymes: Usage Estimates & Trend Analysis

  • 7.1 Market: Usage Movement Analysis
  • 7.2 Research & Biotechnology
    • 7.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.3 Diagnosis
    • 7.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 8 Healthcare Specialty Enzymes: Application Business Analysis

  • 8.1 Market: Application Movement Analysis
  • 8.2 Infectious Disease
    • 8.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.3 Diabetes
    • 8.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.4 Oncology
    • 8.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.5 Cardiology
    • 8.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.6 Nephrology
    • 8.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 8.7 Autoimmune diseases
    • 8.7.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 9 Healthcare Specialty Enzymes: End-use Business Analysis

  • 9.1 Market: End-use Movement Analysis
  • 9.2 Hospitals
    • 9.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.3 Laboratory
    • 9.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 9.4 Others
    • 9.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 10 Healthcare Specialty Enzymes: Regional Business Analysis

  • 10.1 Market: Regional Movement Analysis
  • 10.2 North America
    • 10.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.2.2 U.S.
      • 10.2.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.2.3 Canada
      • 10.2.3.1 Market estimates and forecast, 2016 - 2027 (USD million)
  • 10.3 Europe
    • 10.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.3.2 Germany
      • 10.3.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.3.3 U.K.
      • 10.3.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 10.4 Asia Pacific
    • 10.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.4.2 China
      • 10.4.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.4.3 India
      • 10.4.3.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.4.4 Japan
      • 10.4.4.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 10.5 Latin America
    • 10.5.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.5.2 Brazil
      • 10.5.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)
  • 10.6 Middle East and Africa (MEA)
    • 10.6.1 Market estimates and forecast, 2016 - 2027 (USD Million)
    • 10.6.2 South Africa
      • 10.6.2.1 Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 11 Company Profile

  • 11.1 Strategy Framework
  • 11.2 Market Participation Categorization
  • 11.3 Company Profiles
    • 11.3.1 Advanced Enzymes Technologies Ltd.
      • 11.3.1.1 Company Overview
      • 11.3.1.2 Financial Performance
      • 11.3.1.3 Product Benchmarking
      • 11.3.1.4 Strategic Initiatives
    • 11.3.2 Amano Enzymes, Inc.
      • 11.3.2.1 Company Overview
      • 11.3.2.2 Financial Performance
      • 11.3.2.3 Product Benchmarking
      • 11.3.2.4 Strategic Initiatives
    • 11.3.3 Amicogen
      • 11.3.3.1 Company Overview
      • 11.3.3.2 Financial Performance
      • 11.3.3.3 Product Benchmarking
      • 11.3.3.4 Strategic Initiatives
    • 11.3.4 BBI Solutions
      • 11.3.4.1 Company Overview
      • 11.3.4.2 Financial Performance
      • 11.3.4.3 Product Benchmarking
    • 11.3.5 biotechrabbit GmbH
      • 11.3.5.1 Company Overview
      • 11.3.5.2 Financial Performance
      • 11.3.5.3 Product Benchmarking
      • 11.3.5.4 Strategic Initiatives
    • 11.3.6 Brain AG
      • 11.3.6.1 Company Overview
      • 11.3.6.2 Financial Performance
      • 11.3.6.3 Biocatalysts
      • 11.3.6.3.1 Company Overview
      • 11.3.6.3.2 Product Benchmarking
      • 11.3.6.3.3 Strategic Initiatives
    • 11.3.7 CPC Biotech
      • 11.3.7.1 Company Overview
      • 11.3.7.2 Financial Performance
      • 11.3.7.3 Product Benchmarking
      • 11.3.7.4 Strategic Initiatives
    • 11.3.8 Creative Enzymes
      • 11.3.8.1 Company Overview
      • 11.3.8.2 Financial Performance
      • 11.3.8.3 Product Benchmarking
      • 11.3.8.4 Strategic Initiatives
    • 11.3.9 EKF Diagnostics
      • 11.3.9.1 Company Overview
      • 11.3.9.2 Financial Performance
      • 11.3.9.3 Product Benchmarking
      • 11.3.9.4 Strategic Initiatives
    • 11.3.10 F. Hoffmann-La Roche Ltd
      • 11.3.10.1 Company Overview
      • 11.3.10.2 Financial Performance
      • 11.3.10.3 Custom Biotech
      • 11.3.10.3.1 Company Overview
      • 11.3.10.3.2 Product Benchmarking
    • 11.3.11 Merck Group/KGaA
      • 11.3.11.1 Company Overview
      • 11.3.11.2 Sigma-Aldrich (Millipore Sigma)
      • 11.3.11.2.1 Product Benchmarking
      • 11.3.11.3 Financial Performance
      • 11.3.11.4 Strategic Initiatives
    • 11.3.12 Sekisui Chemical Co., Ltd.
      • 11.3.12.1 Company Overview
      • 11.3.12.2 Financial Performance
      • 11.3.12.3 Strategic Initiatives
      • 11.3.12.4 Sekisui Medical Co., Ltd
      • 11.3.12.4.1 Company Overview
      • 11.3.12.4.2 Sekisui Diagnostics
    • 11.3.13 Thermo Fisher Scientific, Inc.
      • 11.3.13.1 Company Overview
      • 11.3.13.2 Financial Performance
      • 11.3.13.3 Product Benchmarking
      • 11.3.13.4 Strategic Initiatives

List of Tables

  • TABLE 1 Applications of amperometric enzyme-based biosensors
  • TABLE 2 Role of specialty enzymes in the prognosis of cancer
  • TABLE 3 Companies offering lipase suitable for diagnostic applications
  • TABLE 4 Companies offering lipase suitable for diagnostic applications
  • TABLE 5 Specialty enzymes provided by EKF Diagnostics
  • TABLE 6 Diagnostic enzymes from microorganisms: Creative Enzymes
  • TABLE 7 Molecular diagnostic specialty enzymes commercialized by Sigma Aldrich
  • TABLE 8 Role of specialty enzymes in the microbial technology
  • TABLE 9 Specialty enzymes in the diagnosis
  • TABLE 10 Reference intervals for blood glucose in adults (fasting) via three enzymatic methods
  • TABLE 11 Commercial cardiac enzymes available in the market
  • TABLE 12 Currently available enzyme-based assays for creatinine measurement
  • TABLE 13 North America healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 14 North America healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 15 North America healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 16 North America healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 17 North America healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 18 North America healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 22 U.S. healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 23 U.S. healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 24 U.S. healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 25 Canada healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 26 Canada healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 27 Canada healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 28 Canada healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 29 Canada healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 30 Canada healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 31 Europe healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 32 Europe healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 33 Europe healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 34 Europe healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 35 Europe healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 36 Europe healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 37 Germany healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 38 Germany healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 39 Germany healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 40 Germany healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 41 Germany healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 42 Germany healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 43 U.K. healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 44 U.K. healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 45 U.K. healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 46 U.K. healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 47 U.K. healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 48 U.K. healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 49 Asia Pacific healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 50 Asia Pacific healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 51 Asia Pacific healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 52 Asia Pacific healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 53 Asia Pacific healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 54 Asia Pacific healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 55 China healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 56 China healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 57 China healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 58 China healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 59 China healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 60 China healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 61 India healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 62 India healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 63 India healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 64 India healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 65 India healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 66 India healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 67 Japan healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 68 Japan healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 69 Japan healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 70 Japan healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 71 Japan healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 72 Japan healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 73 Latin America healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 74 Latin America healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 75 Latin America healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 76 Latin America healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 77 Latin America healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 78 Latin America healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 79 Brazil healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 80 Brazil healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 81 Brazil healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 82 Brazil healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 83 Brazil healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 84 Brazil healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 85 MEA healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 86 MEA healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 87 MEA healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 88 MEA healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 89 MEA healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 90 MEA healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 91 South Africa healthcare specialty enzymes market, by product, 2016 - 2027 (USD Million)
  • TABLE 92 South Africa healthcare specialty enzymes market, by technique, 2016 - 2027 (USD Million)
  • TABLE 93 South Africa healthcare specialty enzymes market, by source, 2016 - 2027 (USD Million)
  • TABLE 94 South Africa healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)
  • TABLE 95 South Africa healthcare specialty enzymes market, by end use, 2016 - 2027 (USD Million)
  • TABLE 96 South Africa healthcare specialty enzymes market, by application, 2016 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market Capitalization of Top Ten Biotechnology Companies
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping for products, 2018
  • FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Transitions in the enzyme industry
  • FIG. 17 Healthcare specialty enzymes market: Product type outlook key takeaways
  • FIG. 18 Healthcare specialty enzymes market: Product market movement analysis
  • FIG. 19 Global carbohydrases healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 20 Global polymerases and nucleases healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 21 Global proteases healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 22 Global lipases healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 23 Global phosphatases/phytases healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 24 Global other products healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 25 Healthcare specialty enzymes market: Source type outlook key takeaways
  • FIG. 26 Healthcare specialty enzymes market: Source market movement analysis
  • FIG. 27 Global microbial healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 28 Global animal-derived healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 29 Global plant-derived healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 30 Healthcare specialty enzymes market: Technique type outlook key takeaways
  • FIG. 31 Healthcare specialty enzymes market: Technique market movement analysis
  • FIG. 32 Applications of immobilized enzymes in clinical chemistry
  • FIG. 33 Global clinical chemistry healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 34 Global molecular diagnostics healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 35 Global immunodiagnostics healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 36 Global microbiology healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 37 Global hematology healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 38 Healthcare specialty enzymes market: Usage type outlook key takeaways
  • FIG. 39 Healthcare specialty enzymes market: Usage market movement analysis
  • FIG. 40 Global research & biotechnology healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 41 Global diagnostic healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 42 Healthcare specialty enzymes market: Application type outlook key takeaways
  • FIG. 43 Healthcare specialty enzymes market: Application market movement analysis
  • FIG. 44 Global infectious disease healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 45 Global diabetes healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 46 Global oncology healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 47 Global cardiology healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 48 Global nephrology healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 49 Global autoimmune diseases healthcare specialty enzyme market, 2016 - 2027 (USD Million)
  • FIG. 50 Healthcare specialty enzymes market: End-use type outlook key takeaways
  • FIG. 51 Healthcare specialty enzymes market: End-use market movement analysis
  • FIG. 52 Global hospital healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 53 Global laboratory healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 54 Global other healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 55 Regional market place: Key takeaways
  • FIG. 56 Healthcare specialty enzymes market by region: Regional movement analysis
  • FIG. 57 North America healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 58 U.S. healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 59 Canada healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 60 Europe healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 61 Germany healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 62 U.K. healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 63 Asia Pacific healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 64 China healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 65 India healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 66 Japan healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 67 Latin America healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 68 Brazil healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 69 MEA healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 70 South Africa healthcare specialty enzymes market, 2016 - 2027 (USD Million)
  • FIG. 71 Strategy framework
  • FIG. 72 Participant categorization